| # | Drug | Count |
|---|---|---|
| 0 | OCRELIZUMAB | 52 |
| 1 | LEVONORGESTREL | 34 |
| 2 | IBUPROFEN | 32 |
| 3 | FINGOLIMOD HCL | 29 |
| 4 | IBUPFROFEN | 29 |
| 5 | IBUPROFEN 200 MG | 29 |
| 6 | IBUPROFEN 200MG | 29 |
| 7 | IBUPROFEN CAPSULE | 29 |
| 8 | IBUPROFEN CAPSULES 200 MG | 29 |
| 9 | IBUPROFEN ORAL | 29 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CHASTE TREE FRUIT | 1 | 0.0417 |
| 1 | ACYCLOVIR AND HYDROCORTISONE | 1 | 0.0250 |
| 2 | TRASTUZUMAB AND HYALURONIDASE-OYSK | 1 | 0.0093 |
| 3 | ADALIMUMAB-ADBM | 1 | 0.0037 |
| 4 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 5 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| 6 | ACETIC ACID | 1 | 0.0028 |
| 7 | L-TRYPTOPHAN | 1 | 0.0023 |
| 8 | ETONOGESTREL AND ETHINYL ESTRADIOL | 28 | 0.0013 |
| 9 | FINGOLIMOD HYDROCHLORIDE | 6 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 69 |
| 1 | Progestin [EPC] | 65 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 48 |
| 3 | Corticosteroid [EPC] | 47 |
| 4 | Estrogen [EPC] | 42 |
| 5 | Tumor Necrosis Factor Blocker [EPC] | 37 |
| 6 | Progestin-containing Intrauterine System [EPC] | 34 |
| 7 | Integrin Receptor Antagonist [EPC] | 26 |
| 8 | Vitamin C [EPC] | 25 |
| 9 | Benzodiazepine [EPC] | 22 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 1 | Endoglycosidase [EPC] | 1 | 0.0005 |
| 2 | Provitamin D2 Compound [EPC] | 14 | 0.0005 |
| 3 | CD52-directed Cytolytic Antibody [EPC] | 9 | 0.0005 |
| 4 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 6 | 0.0004 |
| 5 | Copper-containing Intrauterine Device [EPC] | 15 | 0.0003 |
| 6 | Integrin Receptor Antagonist [EPC] | 26 | 0.0003 |
| 7 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 8 | Estrogen [EPC] | 42 | 0.0002 |
| 9 | Progestin [EPC] | 65 | 0.0002 |